Sequence Bio Raises $1.6M in Equity | GenomeWeb

NEW YORK (GenomeWeb) – Sequence Bioinformatics has raised $1.6 million in equity financing, according to a Form D the company filed with the US Securities and Exchange Commission last month.

The Newfoundland, Canada-based firm also raised C$1 million ($775,000) last year from Killick Capital, Pelorus Venture Capital, and Klister Credit. It did not specify the reason for the current financing or what it plans to do with the proceeds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.